Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 11, Novembre 2012
Page(s) 951 - 957
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20122811013
Publié en ligne 12 novembre 2012
  1. Saulnier-Blache JS. L’acide lysophosphatidique : un phospholipide bioactif. Med Sci (Paris) 2004 ; 20 : 799–803. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Lee MJ, Van Brocklyn JR, Thangada S, et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998 ; 279 : 1552–1555. [CrossRef] [PubMed] [Google Scholar]
  3. Liu Y, Wada R, Yamashita T, et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000 ; 106 : 951–961. [CrossRef] [PubMed] [Google Scholar]
  4. MacLennan AJ, Carney PR, Zhu WJ, et al. An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 2001 ; 14 : 203–209. [CrossRef] [PubMed] [Google Scholar]
  5. Kono M, Belyantseva IA, Skoura A, et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 2007 ; 282 : 10690–10696. [CrossRef] [PubMed] [Google Scholar]
  6. Schulze T, Golfier S, Tabeling C, et al. Sphingosine-1-phosphate receptor 4 (S1P) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J 2011 ; 25 : 4024–4036. [CrossRef] [PubMed] [Google Scholar]
  7. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999 ; 99 : 301–312. [CrossRef] [PubMed] [Google Scholar]
  8. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006 ; 281 : 34381–34393. [CrossRef] [PubMed] [Google Scholar]
  9. Sanchez T, Skoura A, Wu MT, et al. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 2007 ; 27 : 1312–1318. [CrossRef] [PubMed] [Google Scholar]
  10. Niessen F, Furlan-Freguia C, Fernandez JA, et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009 ; 113 : 2859–2866. [CrossRef] [PubMed] [Google Scholar]
  11. Chae SS, Paik JH, Furneaux H, Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 2004 ; 114 : 1082–1089. [PubMed] [Google Scholar]
  12. Salomone S, Potts EM, Tyndall S, et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 2008 ; 153 : 140–147. [CrossRef] [PubMed] [Google Scholar]
  13. Szczepaniak WS, Pitt BR, McVerry BJ. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. Am J Physiol Lung Cell Mol Physiol 2010 ; 299 : L137–L145. [CrossRef] [PubMed] [Google Scholar]
  14. Nofer JR, van der Giet M, Tolle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004 ; 113 : 569–581. [PubMed] [Google Scholar]
  15. Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006 ; 114 : 1403–1409. [CrossRef] [PubMed] [Google Scholar]
  16. Whetzel AM, Bolick DT, Srinivasan S, et al. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res 2006 ; 99 : 731–739. [CrossRef] [PubMed] [Google Scholar]
  17. Wang F, Okamoto Y, Inoki I, et al. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 2010 ; 120 : 3979–3995. [CrossRef] [PubMed] [Google Scholar]
  18. Zhang J, Honbo N, Goetzl EJ, et al. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 2007 ; 293 : H3150–H3158. [CrossRef] [PubMed] [Google Scholar]
  19. Vessey DA, Li L, Kelley M, Karliner JS. Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia. Biochem Biophys Res Commun 2008 ; 375 : 425–429. [CrossRef] [PubMed] [Google Scholar]
  20. Means CK, Xiao CY, Li Z, et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007 ; 292 : H2944–H2951. [CrossRef] [PubMed] [Google Scholar]
  21. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002 ; 296 : 346–349. [CrossRef] [PubMed] [Google Scholar]
  22. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004 ; 427 : 355–360. [CrossRef] [PubMed] [Google Scholar]
  23. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 2004 ; 279 : 15396–15401. [CrossRef] [PubMed] [Google Scholar]
  24. Allende ML, Tuymetova G, Lee BG, et al. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 2010 ; 207 : 1113–1124. [CrossRef] [PubMed] [Google Scholar]
  25. Nofer JR, Bot M, Brodde M, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2007 ; 115 : 501–508. [CrossRef] [PubMed] [Google Scholar]
  26. Hughes JE, Srinivasan S, Lynch KR, et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 2008 ; 102 : 950–958. [CrossRef] [PubMed] [Google Scholar]
  27. Weigert A, Johann AM, von Knethen A, et al. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 2006 ; 108 : 1635–1642. [CrossRef] [PubMed] [Google Scholar]
  28. Mizugishi K, Yamashita T, Olivera A, et al. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005 ; 25 : 11113–11121. [CrossRef] [PubMed] [Google Scholar]
  29. Jaillard C, Harrison S, Stankoff B, et al. Edg8/S1P5 : an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 2005 ; 25 : 1459–1469. [CrossRef] [PubMed] [Google Scholar]
  30. Novgorodov AS, El-Alwani M, Bielawski J, et al. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 2007 ; 21 : 1503–1514. [CrossRef] [PubMed] [Google Scholar]
  31. Fujino M, Funeshima N, Kitazawa Y, et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003 ; 305 : 70–77. [CrossRef] [PubMed] [Google Scholar]
  32. Webb M, Tham CS, Lin FF, et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004 ; 153 : 108–121. [CrossRef] [PubMed] [Google Scholar]
  33. Rausch M, Hiestand P, Foster CA, et al. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking : clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004 ; 20 : 16–24. [CrossRef] [PubMed] [Google Scholar]
  34. Jung CG, Kim HJ, Miron VE, et al. Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 2007 ; 55 : 1656–1667. [CrossRef] [PubMed] [Google Scholar]
  35. Mege JL, Capo C. La polarisation des macrophages, le nœud gordien des infections bactériennes. Med Sci (Paris) 2010 ; 26 : 83–88. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.